Article

A multi-omics dataset for the analysis of Frontotemporal Dementia genetic subtypes

2020-12-02

Abstract excerpt

Understanding the molecular mechanisms underlying frontotemporal dementia (FTD) is essential for the development of successful therapies. Systematic studies on human post-mortem brain tissue of patients with genetic subtypes of FTD are currently lacking. The Risk and Modyfing Factors of Frontotemporal Dementia (RiMod-FTD) consortium therefore has generated a multi-omics dataset for genetic subtypes of FTD to ident...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 08a90c56-0932-527f-91fb-dc42e1db775a
DOI: 10.1101/2020.12.01.405894

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A multi-omics dataset for the analysis of Frontotemporal Dementia genetic subtypesDOI 10.1101/2020.12.01.405894Read

A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes.Semantic proximity Read

A Multi-omics Data Resource for Frontotemporal Dementia Research.Semantic proximity Read

Integrated multi-omics analysis reveals common and distinct dysregulated pathways for genetic subtypes of Frontotemporal DementiaSemantic proximity Read

Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals <i>OTUD4</i> in shared dysregulated signatures across pathological subtypesSemantic proximity Read

Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients.Semantic proximity Read

Genome Wide Association Study and Next Generation Sequencing: A Glimmer of Light Toward New Possible Horizons in Frontotemporal Dementia ResearchSemantic proximity Read

Transcriptome-wide Association Study in Frontotemporal Dementia Identifies New Disease Loci by In Silico Analysis.Semantic proximity Read

Frontotemporal dementia and its subtypes: a genome-wide association study.Semantic proximity Read

Genetic and Multi-omic Risk Assessment of Alzheimer’s Disease Implicates Core Associated Biological DomainsSemantic proximity Read

The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.Semantic proximity Read

Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s diseaseSemantic proximity Read

Exploring Common Therapeutic Targets for Neurodegenerative Disorders Using Transcriptome StudySemantic proximity Read